BRD3308

1 Cited Publications
Customer Review

Based on 1 publication(s) in Google Scholar

BRD3308 is a highly selective HDAC3 inhibitor with an IC50 of 54 nM. BRD3308 is 23-fold selectivity for HDAC3 over HDAC1 (IC50 of 1.26 μM) or HDAC2 (IC50 of 1.34 μM). BRD3308 suppresses pancreatic β-cell apoptosis induced by inflammatory cytokines or glucolipotoxic stress, and increases functional insulin release. BRD3308 activates HIV-1 transcription and disrupts HIV-1 latency.

For research use only. We do not sell to patients.

  • Purity: 98.34%
  • CAS No.: 1550053-02-5
  • Formula: C15H14FN3O2
  • Molecular Weight:287.29
  • Storage:
    Powder   -20°C, 3 years , 4°C, 2 years ; In solvent   -80°C, 6 months , -20°C, 1 month
  • Biological Activity
  • Chemical Information
  • Solvent & Solubility
  • Purity & Documentation
  • References
  • Help & FAQs
You May Still Need

Publications Citing Use of MedChemExpress (MCE) BRD3308

More
Customer Validation & Images
WB
  • WB

All HIV Isoforms

More
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00